HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Li Selected Research

fluorescein isothiocyanate-polyethylenimine

11/2014Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Li Research Topics

Disease

536Neoplasms (Cancer)
10/2022 - 04/2000
192Inflammation (Inflammations)
12/2022 - 05/2006
120Infections
07/2022 - 02/2004
90Hypertension (High Blood Pressure)
09/2022 - 08/2002
79Neoplasm Metastasis (Metastasis)
07/2022 - 02/2003
77Breast Neoplasms (Breast Cancer)
01/2022 - 03/2005
63Type 2 Diabetes Mellitus (MODY)
01/2022 - 09/2007
61Lung Neoplasms (Lung Cancer)
07/2022 - 06/2008
58Insulin Resistance
06/2022 - 07/2004
57Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2022 - 08/2008
56Obesity
01/2022 - 05/2003
56Fibrosis (Cirrhosis)
01/2022 - 01/2007
51Body Weight (Weight, Body)
06/2022 - 05/2003
50Carcinogenesis
03/2022 - 04/2000
48Hypoxia (Hypoxemia)
12/2022 - 07/2009
48Pain (Aches)
11/2022 - 06/2009
44Wounds and Injuries (Trauma)
10/2022 - 03/2006
44Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 08/2002
44Hepatocellular Carcinoma (Hepatoma)
04/2022 - 06/2006
44Stroke (Strokes)
01/2022 - 08/2002
28Alzheimer Disease (Alzheimer's Disease)
10/2022 - 05/2010
28Myocardial Infarction
10/2022 - 05/2009
28Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 11/2007
27Atherosclerosis
10/2022 - 01/2007
27Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2009
26Stomach Neoplasms (Stomach Cancer)
02/2022 - 03/2006
25COVID-19
03/2022 - 01/2020
25Prostatic Neoplasms (Prostate Cancer)
03/2022 - 05/2002
24Ischemic Stroke
09/2022 - 04/2006
24Leukemia
01/2022 - 03/2007
24Carcinoma (Carcinomatosis)
10/2021 - 04/2000
23Reperfusion Injury
12/2022 - 01/2008
22Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 09/2010
22Adenocarcinoma of Lung
01/2021 - 05/2010
21Heart Failure
01/2022 - 03/2012
21Ischemia
02/2021 - 04/2006
21Hyperglycemia
05/2020 - 05/2004
20Cognitive Dysfunction
06/2022 - 10/2009
20Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 01/2012
20Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 03/2006
20Glioma (Gliomas)
03/2022 - 05/2014
20Hypersensitivity (Allergy)
10/2021 - 07/2005
19Brain Ischemia (Cerebral Ischemia)
09/2022 - 05/2007
19Sepsis (Septicemia)
01/2022 - 06/2009
19Dry Eye Syndromes (Dry Eye Syndrome)
12/2021 - 01/2015
19Rhinosinusitis
08/2021 - 03/2012

Drug/Important Bio-Agent (IBA)

212Proteins (Proteins, Gene)FDA Link
12/2022 - 04/2000
149Biomarkers (Surrogate Marker)IBA
10/2022 - 04/2000
132Pharmaceutical PreparationsIBA
08/2022 - 08/2003
88Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2002
85CytokinesIBA
09/2022 - 06/2006
81Biological ProductsIBA
12/2022 - 01/2004
63MicroRNAs (MicroRNA)IBA
10/2022 - 09/2010
62Messenger RNA (mRNA)IBA
01/2022 - 05/2003
60LipidsIBA
02/2022 - 08/2006
47Therapeutic UsesIBA
12/2022 - 03/2006
45Long Noncoding RNAIBA
04/2022 - 01/2015
45DNA (Deoxyribonucleic Acid)IBA
10/2021 - 11/2002
39RNA (Ribonucleic Acid)IBA
03/2022 - 01/2008
39CholesterolIBA
02/2022 - 08/2002
39Insulin (Novolin)FDA Link
01/2022 - 05/2003
38EnzymesIBA
12/2022 - 07/2003
38Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022 - 10/2009
36Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 08/2003
32Peptides (Polypeptides)IBA
01/2022 - 03/2002
31Phosphotransferases (Kinase)IBA
08/2022 - 03/2002
31Triglycerides (Triacylglycerol)IBA
01/2022 - 03/2004
30LigandsIBA
01/2022 - 07/2008
29Interleukin-6 (Interleukin 6)IBA
02/2022 - 06/2006
29Small Interfering RNA (siRNA)IBA
01/2022 - 05/2010
28Indicators and Reagents (Reagents)IBA
03/2022 - 01/2011
27AntigensIBA
10/2022 - 03/2002
27Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2007
26Blood Glucose (Blood Sugar)IBA
01/2022 - 04/2004
24Transcription Factors (Transcription Factor)IBA
05/2022 - 04/2008
24ErbB Receptors (EGF Receptor)IBA
03/2022 - 08/2005
24CollagenIBA
01/2022 - 11/2006
24salicylhydroxamic acid (SHAM)IBA
01/2022 - 06/2009
23AntioxidantsIBA
03/2022 - 02/2012
23CalciumIBA
01/2022 - 01/2005
21Tyrosine Kinase InhibitorsIBA
03/2022 - 12/2009
21Circular RNAIBA
01/2022 - 01/2017
20Retinaldehyde (Retinal)IBA
09/2022 - 06/2009
20Liposomes (Liposome)IBA
12/2021 - 06/2009
20HDL CholesterolIBA
01/2021 - 08/2002
19VaccinesIBA
12/2022 - 03/2002
19Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2012
19Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 03/2005
19C-Reactive ProteinIBA
01/2021 - 01/2009
18SaltsIBA
09/2022 - 03/2012
18CateninsIBA
06/2022 - 08/2015

Therapy/Procedure

276Therapeutics
12/2022 - 08/2002
68Drug Therapy (Chemotherapy)
03/2022 - 04/2008
37Transplantation
10/2022 - 10/2003
30Radiotherapy
05/2022 - 08/2005
28Immunotherapy
03/2022 - 06/2006
25Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 11/2007
21Acupuncture Points (Acupuncture Point)
06/2022 - 10/2008
20Aftercare (After-Treatment)
01/2022 - 06/2009
19Acupuncture Therapy
02/2022 - 03/2006